NLRP3 and myeloid sarcoma: Studies have reported increased expression levels of NLRP3 and IL-1β genes in MS plaques and elevated levels of ASC, caspase-1, and IL-18 in the sera of MS patients (Keane et al., 2018; Voet et al., 2018).